200 related articles for article (PubMed ID: 21990140)
1. MYT1L is a candidate gene for intellectual disability in patients with 2p25.3 (2pter) deletions.
Stevens SJ; van Ravenswaaij-Arts CM; Janssen JW; Klein Wassink-Ruiter JS; van Essen AJ; Dijkhuizen T; van Rheenen J; Heuts-Vijgen R; Stegmann AP; Smeets EE; Engelen JJ
Am J Med Genet A; 2011 Nov; 155A(11):2739-45. PubMed ID: 21990140
[TBL] [Abstract][Full Text] [Related]
2. Refinement of the critical 2p25.3 deletion region: the role of MYT1L in intellectual disability and obesity.
De Rocker N; Vergult S; Koolen D; Jacobs E; Hoischen A; Zeesman S; Bang B; Béna F; Bockaert N; Bongers EM; de Ravel T; Devriendt K; Giglio S; Faivre L; Joss S; Maas S; Marle N; Novara F; Nowaczyk MJ; Peeters H; Polstra A; Roelens F; Rosenberg C; Thevenon J; Tümer Z; Vanhauwaert S; Varvagiannis K; Willaert A; Willemsen M; Willems M; Zuffardi O; Coucke P; Speleman F; Eichler EE; Kleefstra T; Menten B
Genet Med; 2015 Jun; 17(6):460-6. PubMed ID: 25232846
[TBL] [Abstract][Full Text] [Related]
3. Nine newly identified individuals refine the phenotype associated with MYT1L mutations.
Windheuser IC; Becker J; Cremer K; Hundertmark H; Yates LM; Mangold E; Peters S; Degenhardt F; Ludwig KU; Zink AM; Lessel D; Bierhals T; Herget T; Johannsen J; Denecke J; Wohlleber E; Strom TM; Wieczorek D; Bertoli M; Colombo R; Hempel M; Engels H
Am J Med Genet A; 2020 May; 182(5):1021-1031. PubMed ID: 32065501
[TBL] [Abstract][Full Text] [Related]
4. Early-onset obesity and paternal 2pter deletion encompassing the ACP1, TMEM18, and MYT1L genes.
Doco-Fenzy M; Leroy C; Schneider A; Petit F; Delrue MA; Andrieux J; Perrin-Sabourin L; Landais E; Aboura A; Puechberty J; Girard M; Tournaire M; Sanchez E; Rooryck C; Ameil A; Goossens M; Jonveaux P; Lefort G; Taine L; Cailley D; Gaillard D; Leheup B; Sarda P; Geneviève D
Eur J Hum Genet; 2014 Apr; 22(4):471-9. PubMed ID: 24129437
[TBL] [Abstract][Full Text] [Related]
5. MYT1L mutations cause intellectual disability and variable obesity by dysregulating gene expression and development of the neuroendocrine hypothalamus.
Blanchet P; Bebin M; Bruet S; Cooper GM; Thompson ML; Duban-Bedu B; Gerard B; Piton A; Suckno S; Deshpande C; Clowes V; Vogt J; Turnpenny P; Williamson MP; Alembik Y; ; ; Glasgow E; McNeill A
PLoS Genet; 2017 Aug; 13(8):e1006957. PubMed ID: 28859103
[TBL] [Abstract][Full Text] [Related]
6. A novel MYT1L mutation in a patient with severe early-onset obesity and intellectual disability.
Loid P; Mäkitie R; Costantini A; Viljakainen H; Pekkinen M; Mäkitie O
Am J Med Genet A; 2018 Sep; 176(9):1972-1975. PubMed ID: 30055078
[TBL] [Abstract][Full Text] [Related]
7. Chromosome 1p21.3 microdeletions comprising DPYD and MIR137 are associated with intellectual disability.
Willemsen MH; Vallès A; Kirkels LA; Mastebroek M; Olde Loohuis N; Kos A; Wissink-Lindhout WM; de Brouwer AP; Nillesen WM; Pfundt R; Holder-Espinasse M; Vallée L; Andrieux J; Coppens-Hofman MC; Rensen H; Hamel BC; van Bokhoven H; Aschrafi A; Kleefstra T
J Med Genet; 2011 Dec; 48(12):810-8. PubMed ID: 22003227
[TBL] [Abstract][Full Text] [Related]
8. [Genetic diagnosis and analysis of related genes for a pedigree with 2p25 and 12p13 cryptic rearrangements].
Tu X; Zeng J; Cong X; Yan A; Lin Y; Zhang X; Qiu L; Zhou Y; Lan F
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Aug; 31(4):444-8. PubMed ID: 25119907
[TBL] [Abstract][Full Text] [Related]
9. MYT1L-associated neurodevelopmental disorder: description of 40 new cases and literature review of clinical and molecular aspects.
Coursimault J; Guerrot AM; Morrow MM; Schramm C; Zamora FM; Shanmugham A; Liu S; Zou F; Bilan F; Le Guyader G; Bruel AL; Denommé-Pichon AS; Faivre L; Tran Mau-Them F; Tessarech M; Colin E; El Chehadeh S; Gérard B; Schaefer E; Cogne B; Isidor B; Nizon M; Doummar D; Valence S; Héron D; Keren B; Mignot C; Coutton C; Devillard F; Alaix AS; Amiel J; Colleaux L; Munnich A; Poirier K; Rio M; Rondeau S; Barcia G; Callewaert B; Dheedene A; Kumps C; Vergult S; Menten B; Chung WK; Hernan R; Larson A; Nori K; Stewart S; Wheless J; Kresge C; Pletcher BA; Caumes R; Smol T; Sigaudy S; Coubes C; Helm M; Smith R; Morrison J; Wheeler PG; Kritzer A; Jouret G; Afenjar A; Deleuze JF; Olaso R; Boland A; Poitou C; Frebourg T; Houdayer C; Saugier-Veber P; Nicolas G; Lecoquierre F
Hum Genet; 2022 Jan; 141(1):65-80. PubMed ID: 34748075
[TBL] [Abstract][Full Text] [Related]
10. Two patients with intellectual disability, overlapping facial features, and overlapping deletions in 6p25.1p24.3.
Kuipers BC; Vulto-van Silfhout AT; Marcelis C; Pfundt R; de Leeuw N; de Vries BB
Clin Dysmorphol; 2013 Jan; 22(1):18-21. PubMed ID: 23183317
[TBL] [Abstract][Full Text] [Related]
11. Haploinsufficiency of the MYT1L gene causes intellectual disability frequently associated with behavioral disorder.
Mayo S; Roselló M; Monfort S; Oltra S; Orellana C; Martínez F
Genet Med; 2015 Aug; 17(8):683-4. PubMed ID: 26240977
[No Abstract] [Full Text] [Related]
12. Isolated chromosome 8p23.2‑pter deletion: Novel evidence for developmental delay, intellectual disability, microcephaly and neurobehavioral disorders.
Shi S; Lin S; Chen B; Zhou Y
Mol Med Rep; 2017 Nov; 16(5):6837-6845. PubMed ID: 28901431
[TBL] [Abstract][Full Text] [Related]
13. TBR1 is the candidate gene for intellectual disability in patients with a 2q24.2 interstitial deletion.
Palumbo O; Fichera M; Palumbo P; Rizzo R; Mazzolla E; Cocuzza DM; Carella M; Mattina T
Am J Med Genet A; 2014 Mar; 164A(3):828-33. PubMed ID: 24458984
[TBL] [Abstract][Full Text] [Related]
14. A MYT1L syndrome mouse model recapitulates patient phenotypes and reveals altered brain development due to disrupted neuronal maturation.
Chen J; Lambo ME; Ge X; Dearborn JT; Liu Y; McCullough KB; Swift RG; Tabachnick DR; Tian L; Noguchi K; Garbow JR; Constantino JN; Gabel HW; Hengen KB; Maloney SE; Dougherty JD
Neuron; 2021 Dec; 109(23):3775-3792.e14. PubMed ID: 34614421
[TBL] [Abstract][Full Text] [Related]
15. 2p25.3 microduplications involving MYT1L: further phenotypic characterization through an assessment of 16 new cases and a literature review.
Bouassida M; Egloff M; Levy J; Chatron N; Bernardini L; Le Guyader G; Tabet AC; Schluth-Bolard C; Brancati F; Giuffrida MG; Dard R; Clorennec J; Coursimault J; Vialard F; Hervé B
Eur J Hum Genet; 2023 Aug; 31(8):895-904. PubMed ID: 37188826
[TBL] [Abstract][Full Text] [Related]
16. Haploinsufficiency of MBD5 associated with a syndrome involving microcephaly, intellectual disabilities, severe speech impairment, and seizures.
Williams SR; Mullegama SV; Rosenfeld JA; Dagli AI; Hatchwell E; Allen WP; Williams CA; Elsea SH
Eur J Hum Genet; 2010 Apr; 18(4):436-41. PubMed ID: 19904302
[TBL] [Abstract][Full Text] [Related]
17. Study of six patients with complete F9 deletion characterized by cytogenetic microarray: role of the SOX3 gene in intellectual disability.
Jourdy Y; Chatron N; Carage ML; Fretigny M; Meunier S; Zawadzki C; Gay V; Negrier C; Sanlaville D; Vinciguerra C
J Thromb Haemost; 2016 Oct; 14(10):1988-1993. PubMed ID: 27477789
[TBL] [Abstract][Full Text] [Related]
18. Germline mosaic transmission of a novel duplication of PXDN and MYT1L to two male half-siblings with autism.
Meyer KJ; Axelsen MS; Sheffield VC; Patil SR; Wassink TH
Psychiatr Genet; 2012 Jun; 22(3):137-40. PubMed ID: 22157634
[TBL] [Abstract][Full Text] [Related]
19. MYT1L mutation in a patient causes intellectual disability and early onset of obesity: a case report and review of the literature.
Al Tuwaijri A; Alfadhel M
J Pediatr Endocrinol Metab; 2019 Apr; 32(4):409-413. PubMed ID: 30796847
[TBL] [Abstract][Full Text] [Related]
20. Microdeletion at 4q21.3 is associated with intellectual disability, dysmorphic facies, hypotonia, and short stature.
Dukes-Rimsky L; Guzauskas GF; Holden KR; Griggs R; Ladd S; Montoya Mdel C; DuPont BR; Srivastava AK
Am J Med Genet A; 2011 Sep; 155A(9):2146-53. PubMed ID: 21834054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
